The treatment of blocking antibody of IGF-1R remarkably decreased IGF-1R phosphorylation and downstream activation of Akt and Erk1/2, hereby inhibiting tumour growth and causing tumour regression in SCID mice model. Here, IGF1R is linked to neoplasm.